Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Anticancer Research|October 2, 2019
Cardiovascular Risk Factors and Timing of Anthracyclines and Trastuzumab Cardiac ToxicityMaria Laura Canale, Andrea Camerini, Alda Huqi, et al.
Healthcare (Basel, Switzerland)|October 29, 2025
Healthcare Management in Cardio-Oncology, Clinical Strategies and Future Perspectives: A Narrative ReviewVincenzo Quagliariello, Massimiliano Berretta, Fabrizio Maurea, et al.
American Journal of Hypertension|January 2, 2010
Early left ventricular mechanics abnormalities in prehypertension: a two-dimensional strain echocardiography studyVitantonio Di Bello, Enrica Talini, Giulia Dell'Omo, et al.
Biomedicines|August 29, 2024
Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-MetabolismVincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
International Journal of Molecular Sciences|January 11, 2025
Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 ManagementGiuseppina Gallucci, Mario Larocca, Alessandro Navazio, et al.
Frontiers in Cardiovascular Medicine|September 26, 2022
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathwaysVincenzo Quagliariello, Margherita Passariello, Annabella Di Mauro, et al.
Frontiers in Cardiovascular Medicine|February 6, 2023
Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathwaysVincenzo Quagliariello, Margherita Passariello, Annabella Di Mauro, et al.
Cancers|April 27, 2024
The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer PatientsVincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, et al.
International Journal of Molecular Sciences|October 26, 2024
Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer PatientsVincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
Frontiers in Cardiovascular Medicine|July 5, 2021
Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) SurveyMaria Laura Canale, Fabio Turazza, Chiara Lestuzzi, et al.
Pageof 9